Wellesley Asset Management - UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307CAF9. A total of 23 filers reported holding UNITED THERAPEUTICS CORP DEL in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.5%.

Quarter-by-quarter ownership
Wellesley Asset Management ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q4 2015$9,821,000
+19.3%
3,0000.0%0.56%
+16.2%
Q3 2015$8,231,000
-43.0%
3,000
-25.0%
0.48%
-43.3%
Q1 2015$14,430,000
+33.1%
4,0000.0%0.85%
+33.2%
Q4 2014$10,845,000
-8.6%
4,000
-9.1%
0.64%
-13.5%
Q3 2014$11,860,000
+42.8%
4,4000.0%0.74%
+40.8%
Q2 2014$8,308,000
-5.1%
4,4000.0%0.52%
-7.1%
Q1 2014$8,759,000
-18.1%
4,400
-2.2%
0.56%
-25.6%
Q4 2013$10,700,000
+39.7%
4,5000.0%0.76%
+40.3%
Q3 2013$7,661,000
+17.3%
4,5000.0%0.54%
+2.3%
Q2 2013$6,533,000
+5.3%
4,5000.0%0.53%
-0.8%
Q1 2013$6,204,0004,5000.53%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q4 2013
NameSharesValueWeighting ↓
Castle Creek Arbitrage, LLC 39,384,000$141,990,0007.20%
QVT Financial LP 22,500,000$81,122,0004.52%
WOLVERINE ASSET MANAGEMENT LLC 40,750,000$146,884,0002.93%
PIPER SANDLER & CO. 1,500,000$5,404,0002.24%
Wellesley Asset Management 4,000$14,430,0000.85%
SG Americas Securities, LLC 392,500$141,594,0000.84%
CSS LLC/IL 3,500,000$12,653,0000.64%
CQS Cayman LP 1,850,000$6,647,0000.31%
SSI INVESTMENT MANAGEMENT LLC 600,000$2,162,0000.20%
AMERIPRISE FINANCIAL INC 2,500,000$9,006,0000.01%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders